AXIL Brands Inc reported a Q2 2024 calendar-quarter (QQ2 2024) with revenue of $7.73 million and a gross margin of 71.1%, underscoring a high-margin product mix. Net income of $0.634 million and EBITDA of $0.737 million delivered an 8.2% net income margin and a 9.5% EBITDA margin, respectively, as the company continues the brand-transition and channel optimization following the February 2024 name change from Reviv3 Procare to AXIL Brands. While year-over-year (YoY) comparisons show a revenue decline of 8.18% and net income decline of 37.75%, the quarter delivered a robust sequential improvement (QoQ): revenue +32.15%, gross profit +32.37%, and operating income turning positive after a prior negative frame. Free cash flow totaled $0.941 million, and cash at period-end was $5.21 million, yielding a net cash position of approximately -$4.33 million in total debt. The balance sheet remains solid with a current ratio of 2.51 and a cash-to-equity posture supported by modest leverage (long-term debt $0.53 million; total debt $0.88 million). These dynamics suggest a company transitioning brand identity and go-to-market strategy while preserving liquidity to fund selective growth initiatives.